Lanean...
Predictive Biomarkers and Companion Diagnostics. The Future of Immunohistochemistry – ‘in situ proteomics’, or just a ‘stain’?
A ‘companion diagnostic’ is a test for a predictive biomarker, that classifies patients (tumors) into responders and non-responders, for a specified therapeutic agent. Companion diagnostics are designated as Class III medical devices by the FDA, because the test result equates directly to administra...
Gorde:
| Egile nagusia: | |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4215952/ https://ncbi.nlm.nih.gov/pubmed/25203298 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PAI.0000000000000126 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|